HomeCompareATHJF vs NNN

ATHJF vs NNN: Dividend Comparison 2026

ATHJF yields 16666.67% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATHJF wins by $8601297707047409664.00M in total portfolio value
10 years
ATHJF
ATHJF
● Live price
16666.67%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8601297707047409664.00M
Annual income
$8,500,961,637,704,150,000,000,000.00
Full ATHJF calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — ATHJF vs NNN

📍 ATHJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATHJFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATHJF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATHJF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATHJF
Annual income on $10K today (after 15% tax)
$1,416,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,225,817,392,048,527,000,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, ATHJF beats the other by $7,225,817,392,048,527,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATHJF + NNN for your $10,000?

ATHJF: 50%NNN: 50%
100% NNN50/50100% ATHJF
Portfolio after 10yr
$4300648853523704832.00M
Annual income
$4,250,480,818,852,075,000,000,000.00/yr
Blended yield
98.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

ATHJF
No analyst data
Altman Z
-10.7
Piotroski
3/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATHJF buys
0
NNN buys
0
No recent congressional trades found for ATHJF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATHJFNNN
Forward yield16666.67%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$8601297707047409664.00M$25.6K
Annual income after 10y$8,500,961,637,704,150,000,000,000.00$2,637.42
Total dividends collected$8594666089931243520.00M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ATHJF vs NNN ($10,000, DRIP)

YearATHJF PortfolioATHJF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$1,677,367$1,666,666.67$10,737$617.02+$1.67MATHJF
2$263,066,849$261,272,066.46$11,577$710.93+$263.06MATHJF
3$38,576,943,838$38,295,462,310.00$12,538$822.59+$38576.93MATHJF
4$5,289,656,888,585$5,248,379,558,677.81$13,645$956.06+$5289656.87MATHJF
5$678,235,585,150,030$672,575,652,279,244.40$14,925$1,116.51+$678235585.14MATHJF
6$81,321,145,183,775,540$80,595,433,107,665,010.00$16,415$1,310.57+$81321145183.76MATHJF
7$9,118,299,079,523,715,000$9,031,285,454,177,076,000.00$18,158$1,546.77+$9118299079523.70MATHJF
8$956,159,646,381,740,000,000$946,403,066,366,649,700,000.00$20,213$1,836.20+$956159646381740.00MATHJF
9$93,772,027,423,605,150,000,000$92,748,936,601,976,690,000,000.00$22,649$2,193.37+$93772027423605152.00MATHJF
10$8,601,297,707,047,409,000,000,000$8,500,961,637,704,150,000,000,000.00$25,558$2,637.42+$8601297707047409664.00MATHJF

ATHJF vs NNN: Complete Analysis 2026

ATHJFStock

Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.

Full ATHJF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this ATHJF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATHJF vs SCHDATHJF vs JEPIATHJF vs OATHJF vs KOATHJF vs MAINATHJF vs ADCATHJF vs EPRTATHJF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.